http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 16 Jul 2026 11:00:25 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Aptorum+Group+merger+with+DiamiR+to+create+Niki+BioSolutions/26778190.html <p>Aptorum Group Limited (NASDAQ: APM) announced that its merger with DiamiR Biosciences Corp. is expected to close on or about July 20, 2026, according to a press release statement.</p><p>Following the merger, Aptorum will redomicile from the Cayman Islands to Delaware and rename itself Niki BioSolutions, Inc. The combined company is expected to trade on the Nasdaq Capital Market under the ticker symbol "NIKI" as of the market open on July 20, 2026.</p><p>In connection with the merger, Aptorum will execute a 1-for-10 reverse share split, which was approved by shareholders on June 9, 2026. The split will reduce Aptorum's outstanding class http://www.streetinsider.com/Corporate+News/Aptorum+Group+merger+with+DiamiR+to+create+Niki+BioSolutions/26778190.html Thu, 16 Jul 2026 11:00:25 -0400 APM http://www.streetinsider.com/Mergers+and+Acquisitions/Aptorum+Group+merger+with+DiamiR+to+create+Niki+BioSolutions/26778190.html <p>Aptorum Group Limited (NASDAQ: APM) announced that its merger with DiamiR Biosciences Corp. is expected to close on or about July 20, 2026, according to a press release statement.</p><p>Following the merger, Aptorum will redomicile from the Cayman Islands to Delaware and rename itself Niki BioSolutions, Inc. The combined company is expected to trade on the Nasdaq Capital Market under the ticker symbol "NIKI" as of the market open on July 20, 2026.</p><p>In connection with the merger, Aptorum will execute a 1-for-10 reverse share split, which was approved by shareholders on June 9, 2026. The split will reduce Aptorum's outstanding class http://www.streetinsider.com/Mergers+and+Acquisitions/Aptorum+Group+merger+with+DiamiR+to+create+Niki+BioSolutions/26778190.html Thu, 16 Jul 2026 11:00:25 -0400 APM http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger+/26778150.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) ("Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger+/26778150.html Thu, 16 Jul 2026 11:00:00 -0400 APM APM http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger+/26778150.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) ("Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger+/26778150.html Thu, 16 Jul 2026 11:00:00 -0400 APM APM http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger+/26778150.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) ("Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger+/26778150.html Thu, 16 Jul 2026 11:00:00 -0400 APM APM http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger+/26778150.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) ("Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger+/26778150.html Thu, 16 Jul 2026 11:00:00 -0400 APM APM http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) (&quot;Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html Thu, 16 Jul 2026 11:00:00 -0400 A.50204203 A.50216650 APM O.39442858 O.57132792 O.71638566 http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) (&quot;Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html Thu, 16 Jul 2026 11:00:00 -0400 A.50204203 A.50216650 APM O.39442858 O.57132792 O.71638566 http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) (&quot;Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html Thu, 16 Jul 2026 11:00:00 -0400 A.50204203 A.50216650 APM O.39442858 O.57132792 O.71638566 http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) (&quot;Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html Thu, 16 Jul 2026 11:00:00 -0400 A.50204203 A.50216650 APM O.39442858 O.57132792 O.71638566 http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) (&quot;Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html Thu, 16 Jul 2026 11:00:00 -0400 A.50204203 A.50216650 APM O.39442858 O.57132792 O.71638566 http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) (&quot;Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Press+Releases/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html Thu, 16 Jul 2026 11:00:00 -0400 A.50204203 A.50216650 APM O.39442858 O.57132792 O.71638566 http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) (&quot;Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html Thu, 16 Jul 2026 11:00:00 -0400 A.50204203 A.50216650 APM O.39442858 O.57132792 O.71638566 http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) (&quot;Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html Thu, 16 Jul 2026 11:00:00 -0400 A.50204203 A.50216650 APM O.39442858 O.57132792 O.71638566 http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) (&quot;Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html Thu, 16 Jul 2026 11:00:00 -0400 A.50204203 A.50216650 APM O.39442858 O.57132792 O.71638566 http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) (&quot;Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html Thu, 16 Jul 2026 11:00:00 -0400 A.50204203 A.50216650 APM O.39442858 O.57132792 O.71638566 http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) (&quot;Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html Thu, 16 Jul 2026 11:00:00 -0400 A.50204203 A.50216650 APM O.39442858 O.57132792 O.71638566 http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html <p align="justify" style="padding-left:40px;"><b><i>Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger</i></b></p> <p align="justify" style="padding-left:40px;"><b><i>The Merger is Expected to Close in July 2026 </i></b></p> <p align="justify"><strong>NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE) -- </strong> Aptorum Group Limited, a Cayman Islands exempted company with limited liability (NASDAQ: APM) (&quot;Aptorum Group” or “Aptorum” or “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that the closing of its merger with DiamiR Biosciences http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+Provides+Update+on+DiamiR+Biosciences+Merger/26778180.html Thu, 16 Jul 2026 11:00:00 -0400 A.50204203 A.50216650 APM O.39442858 O.57132792 O.71638566 http://www.streetinsider.com/Press+Releases/Aptorum+Group+and+DiamiR+Biosciences+Announce+Three+Presentations+at+2026+Alzheimer%E2%80%99s+Association+International+Conference/26744430.html <p align="justify"><strong>NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, July 08, 2026 (GLOBE NEWSWIRE) -- </strong>Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, and DiamiR Biosciences (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced upcoming presentations at the annual Alzheimer’s Association International Conference (AAIC), taking place at the Excel London Convention &amp; Exhibition Centre, in London, UK, and online, on July 11-15, 2026, showcasing biomarker technologies from DiamiR’s CLIA-certified, CAP-accredited clinical laboratory.</p> <p>Alidad Mireskandari, Ph.D., Chief http://www.streetinsider.com/Press+Releases/Aptorum+Group+and+DiamiR+Biosciences+Announce+Three+Presentations+at+2026+Alzheimer%E2%80%99s+Association+International+Conference/26744430.html Wed, 08 Jul 2026 08:00:00 -0400 APM APM http://www.streetinsider.com/Press+Releases/Aptorum+Group+and+DiamiR+Biosciences+Announce+Three+Presentations+at+2026+Alzheimer%E2%80%99s+Association+International+Conference/26744430.html <p align="justify"><strong>NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, July 08, 2026 (GLOBE NEWSWIRE) -- </strong>Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, and DiamiR Biosciences (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced upcoming presentations at the annual Alzheimer’s Association International Conference (AAIC), taking place at the Excel London Convention &amp; Exhibition Centre, in London, UK, and online, on July 11-15, 2026, showcasing biomarker technologies from DiamiR’s CLIA-certified, CAP-accredited clinical laboratory.</p> <p>Alidad Mireskandari, Ph.D., Chief http://www.streetinsider.com/Press+Releases/Aptorum+Group+and+DiamiR+Biosciences+Announce+Three+Presentations+at+2026+Alzheimer%E2%80%99s+Association+International+Conference/26744430.html Wed, 08 Jul 2026 08:00:00 -0400 APM APM http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+and+DiamiR+Biosciences+Announce+Three+Presentations+at+2026+Alzheimer%E2%80%99s+Association+International+Conference/26744430.html <p align="justify"><strong>NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, July 08, 2026 (GLOBE NEWSWIRE) -- </strong>Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, and DiamiR Biosciences (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced upcoming presentations at the annual Alzheimer’s Association International Conference (AAIC), taking place at the Excel London Convention &amp; Exhibition Centre, in London, UK, and online, on July 11-15, 2026, showcasing biomarker technologies from DiamiR’s CLIA-certified, CAP-accredited clinical laboratory.</p> <p>Alidad Mireskandari, Ph.D., Chief http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+and+DiamiR+Biosciences+Announce+Three+Presentations+at+2026+Alzheimer%E2%80%99s+Association+International+Conference/26744430.html Wed, 08 Jul 2026 08:00:00 -0400 APM APM http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+and+DiamiR+Biosciences+Announce+Three+Presentations+at+2026+Alzheimer%E2%80%99s+Association+International+Conference/26744430.html <p align="justify"><strong>NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, July 08, 2026 (GLOBE NEWSWIRE) -- </strong>Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, and DiamiR Biosciences (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced upcoming presentations at the annual Alzheimer’s Association International Conference (AAIC), taking place at the Excel London Convention &amp; Exhibition Centre, in London, UK, and online, on July 11-15, 2026, showcasing biomarker technologies from DiamiR’s CLIA-certified, CAP-accredited clinical laboratory.</p> <p>Alidad Mireskandari, Ph.D., Chief http://www.streetinsider.com/Globe+Newswire/Aptorum+Group+and+DiamiR+Biosciences+Announce+Three+Presentations+at+2026+Alzheimer%E2%80%99s+Association+International+Conference/26744430.html Wed, 08 Jul 2026 08:00:00 -0400 APM APM http://www.streetinsider.com/SEC+Filings/Form++6-KA++++++Aptorum+Group+Ltd+++++++++For%3A+Jun+22/26673958.html si-local-file:///var/storage/secattach/20260622/26673958.html http://www.streetinsider.com/SEC+Filings/Form++6-KA++++++Aptorum+Group+Ltd+++++++++For%3A+Jun+22/26673958.html Mon, 22 Jun 2026 17:00:00 -0400 APM O.39442858 http://www.streetinsider.com/SEC+Filings/Form++6-KA++++++Aptorum+Group+Ltd+++++++++For%3A+Jun+22/26673958.html si-local-file:///var/storage/secattach/20260622/26673958.html http://www.streetinsider.com/SEC+Filings/Form++6-KA++++++Aptorum+Group+Ltd+++++++++For%3A+Jun+22/26673958.html Mon, 22 Jun 2026 17:00:00 -0400 APM O.39442858 http://www.streetinsider.com/Corporate+News/DiamiR+and+AlzLabs+team+up+on+Alzheimer%27s+blood+biomarker+study/26670223.html <p>DiamiR Biosciences Corp. and AlzLabs Precision Diagnostics have announced a collaboration to generate protein and microRNA blood-based biomarker data focused on Alzheimer's disease, according to a statement from Aptorum Group Limited (NASDAQ: APM).</p><p>The study will measure blood biomarkers of neurodegeneration, including p-Tau 217, amyloid 42/40, and neurofilament light (NfL), using blood plasma samples from participants whose amyloid status was determined by amyloid PET imaging. DiamiR plans to evaluate these biomarker panels both as standalone tests and in combination with its proprietary microRNA platform technology, CogniMIR®.</p><p>"Our objective is to evaluate these biomarker panels as standalone tests and in combination with DiamiR's http://www.streetinsider.com/Corporate+News/DiamiR+and+AlzLabs+team+up+on+Alzheimer%27s+blood+biomarker+study/26670223.html Mon, 22 Jun 2026 08:02:59 -0400 APM